Press Releases
Mar 8, 2023
PreciseDx to Present on AI-enabled Breast Cancer Grade and Phenotyping Assay at United States and Canadian Academy of Pathology (USCAP) Annual Meeting
See More
Mar 8, 2023
PreciseDx to Present on AI-enabled Breast Cancer Grade and Phenotyping Assay at United States and Canadian Academy of Pathology (USCAP) Annual Meeting
See More
Media Coverage
Feb 20, 2023
New York and Florida Embrace AI-powered Oncology Tools
See More
Feb 20, 2023
New York and Florida Embrace AI-powered Oncology Tools
See More
Media Coverage
Feb 14, 2023
Filling a Global Gap: How technology can alleviate the impact of the global pathologist shortage
See More
Feb 14, 2023
Filling a Global Gap: How technology can alleviate the impact of the global pathologist shortage
See More
Press Releases
Feb 7, 2023
PreciseDx Receives New York State Approval for an AI-Enabled Breast Diagnostic
See More
Feb 7, 2023
PreciseDx Receives New York State Approval for an AI-Enabled Breast Diagnostic
See More
Jan 31, 2023
PreciseDx Appoints Paul Roma as Chairman of the Board
See More
Jan 31, 2023
PreciseDx Appoints Paul Roma as Chairman of the Board
See More
Media Coverage
Jan 31, 2023
Technology’s Role In Determining Cancer Treatment
See More
Jan 31, 2023
Technology’s Role In Determining Cancer Treatment
See More
Press Releases
Jan 19, 2023
PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard
See More
Jan 19, 2023
PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard
See More
Media Coverage
Jan 11, 2023
Demystifying AI's role in healthcare to reassure new providers – and old pros
See More
Jan 11, 2023
Demystifying AI's role in healthcare to reassure new providers – and old pros
See More
Publications
Dec 21, 2022
Development and Validation of an AI-Enabled Digital Breast Cancer Assay to Predict Early-Stage Breast Cancer Recurrence Within 6 Years
See More
Dec 21, 2022
Development and Validation of an AI-Enabled Digital Breast Cancer Assay to Predict Early-Stage Breast Cancer Recurrence Within 6 Years
See More
No results.
Contact us today to learn more about PreciseBreast.
